User menu

Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.

Bibliographic reference Araújo, Francisca ; Shrestha, Neha ; Granja, Pedro L ; Hirvonen, Jouni ; Santos, Hélder A ; et. al. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.. In: Expert Opinion on Drug Metabolism & Toxicology, Vol. 11, no.3, p. 381-393 (2014)
Permanent URL
  1. Nahar Manoj, Mishra Dinesh, Dubey Vaibhav, Jain Narendra Kumar, Development, characterization, and toxicity evaluation of amphotericin B–loaded gelatin nanoparticles, 10.1016/j.nano.2008.03.007
  2. Jain Amit K., Swarnakar Nitin K., Godugu Chandraiah, Singh Raman P., Jain Sanyog, The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen, 10.1016/j.biomaterials.2010.09.037
  3. Foldvari Marianna, Bagonluri Mukasa, Carbon nanotubes as functional excipients for nanomedicines: I. pharmaceutical properties, 10.1016/j.nano.2008.04.002
  4. Shahbazi Mohammad-Ali, Almeida Patrick V., Mäkilä Ermei M., Kaasalainen Martti H., Salonen Jarno J., Hirvonen Jouni T., Santos Hélder A., Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering, 10.1016/j.biomaterials.2014.05.020
  5. Das Surajit, Chaudhury Anumita, Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery, 10.1208/s12249-010-9563-0
  6. Plapied Laurence, Duhem Nicolas, des Rieux Anne, Préat Véronique, Fate of polymeric nanocarriers for oral drug delivery, 10.1016/j.cocis.2010.12.005
  7. Choonara Bibi F., Choonara Yahya E., Kumar Pradeep, Bijukumar Divya, du Toit Lisa C., Pillay Viness, A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules, 10.1016/j.biotechadv.2014.07.006
  8. Ensign Laura M., Cone Richard, Hanes Justin, Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers, 10.1016/j.addr.2011.12.009
  9. Schenk Mirjam, Mueller Christoph, The mucosal immune system at the gastrointestinal barrier, 10.1016/j.bpg.2007.11.002
  10. Bakhru Sasha H., Furtado Stacia, Morello A. Peter, Mathiowitz Edith, Oral delivery of proteins by biodegradable nanoparticles, 10.1016/j.addr.2013.04.006
  11. Yun Yeonhee, Cho Yong Woo, Park Kinam, Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery, 10.1016/j.addr.2012.10.007
  12. Araújo Francisca, Shrestha Neha, Shahbazi Mohammed-Ali, Fonte Pedro, Mäkilä Ermei M., Salonen Jarno J., Hirvonen Jouni T., Granja Pedro L., Santos Hélder A., Sarmento Bruno, The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium, 10.1016/j.biomaterials.2014.07.026
  13. Li Xiuying, Guo Shiyan, Zhu Chunliu, Zhu Quanlei, Gan Yong, Rantanen Jukka, Rahbek Ulrik Lytt, Hovgaard Lars, Yang Mingshi, Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles, 10.1016/j.biomaterials.2013.08.048
  14. Khan Jesmine, Iiboshi Yasuhiko, Cui Li, Wasa Masafumi, Okada Akira, Role of Intestinal Mucus on the Uptake of Latex Beads by Peyer's Patches and on Their Transport to Mesenteric Lymph Nodes in Rats, 10.1177/014860719902300119
  15. Albanese CT, Surgery, 116, 76 (1994)
  16. Lamprecht Alf, Schäfer Ulrich, Lehr Claus‐Michael, 10.1023/a:1011032328064
  17. Pridgen Eric M., Alexis Frank, Farokhzad Omid C., Polymeric Nanoparticle Technologies for Oral Drug Delivery, 10.1016/j.cgh.2014.06.018
  18. Hochman Jerome, Artursson Per, Mechanisms of absorption enhancement and tight junction regulation, 10.1016/0168-3659(94)90072-8
  19. des Rieux Anne, Pourcelle Vincent, Cani Patrice D., Marchand-Brynaert Jacqueline, Préat Véronique, Targeted nanoparticles with novel non-peptidic ligands for oral delivery, 10.1016/j.addr.2013.01.002
  20. des Rieux Anne, Fievez Virginie, Garinot Marie, Schneider Yves-Jacques, Préat Véronique, Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach, 10.1016/j.jconrel.2006.08.013
  21. Chen Mei-Chin, Sonaje Kiran, Chen Ko-Jie, Sung Hsing-Wen, A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery, 10.1016/j.biomaterials.2011.08.087
  22. McClements David Julian, Edible lipid nanoparticles: Digestion, absorption, and potential toxicity, 10.1016/j.plipres.2013.04.008
  23. The cell: a molecular approach (2000)
  24. Hillaireau Hervé, Couvreur Patrick, Nanocarriers’ entry into the cell: relevance to drug delivery, 10.1007/s00018-009-0053-z
  25. Rekha M.R., Sharma Chandra P., Oral delivery of therapeutic protein/peptide for diabetes – Future perspectives, 10.1016/j.ijpharm.2012.03.056
  26. Florence Alexander T., Nanoparticle uptake by the oral route: Fulfilling its potential?, 10.1016/j.ddtec.2005.05.019
  27. Kean T., Thanou M., Biodegradation, biodistribution and toxicity of chitosan, 10.1016/j.addr.2009.09.004
  28. Arora Sumit, Rajwade Jyutika M., Paknikar Kishore M., Nanotoxicology and in vitro studies: The need of the hour, 10.1016/j.taap.2011.11.010
  29. Reis Catarina P., Figueiredo Isabel V., Carvalho Rui A., Jones John, Nunes Patrícia, Soares Ana F., Silva Cristina F., Ribeiro António J., Veiga Francisco J., Damgé Christiane, Cabrita António M. S., Neufeld Ronald J., Toxicological assessment of orally delivered nanoparticulate insulin, 10.1080/17435390802398309
  30. Fonte Pedro, Araújo Francisca, Reis Salette, Sarmento Bruno, Oral Insulin Delivery: How Far are We?, 10.1177/193229681300700228
  31. Yeh Tzyy-Harn, Hsu Li-Wen, Tseng Michael T., Lee Pei-Ling, Sonjae Kiran, Ho Yi-Cheng, Sung Hsing-Wen, Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening, 10.1016/j.biomaterials.2011.03.056
  32. Sonaje K, Mol Pharm, 9, 1271 (2012)
  33. Werle Martin, Takeuchi Hirofumi, Bernkop-Schnürch Andreas, Modified Chitosans for Oral Drug Delivery, 10.1002/jps.21550
  34. Baldrick Paul, The safety of chitosan as a pharmaceutical excipient, 10.1016/j.yrtph.2009.09.015
  35. Chiu Gigi, Wong Man-Yi, Ling Leong-Uung, Shaikh Ishaque, Tan Kuan-Boone, Chaudhury Anumita, Tan Bee-Jen, Lipid-Based Nanoparticulate Systems for the Delivery of Anti-Cancer Drug Cocktails: Implications on Pharmacokinetics and Drug Toxicities, 10.2174/138920009790274531
  36. Morishita Mariko, Peppas Nicholas A., Is the oral route possible for peptide and protein drug delivery?, 10.1016/j.drudis.2006.08.005
  37. Gan Quan, Wang Tao, Chitosan nanoparticle as protein delivery carrier—Systematic examination of fabrication conditions for efficient loading and release, 10.1016/j.colsurfb.2007.04.009
  38. Muzzarelli Riccardo A.A., Greco Francesco, Busilacchi Alberto, Sollazzo Vincenzo, Gigante Antonio, Chitosan, hyaluronan and chondroitin sulfate in tissue engineering for cartilage regeneration: A review, 10.1016/j.carbpol.2012.04.057
  39. Hejazi Radi, Amiji Mansoor, Chitosan-based gastrointestinal delivery systems, 10.1016/s0168-3659(03)00126-3
  40. Chae Su Young, Jang Mi-Kyeong, Nah Jae-Woon, Influence of molecular weight on oral absorption of water soluble chitosans, 10.1016/j.jconrel.2004.10.012
  41. Zheng Fang, Shi Xiao-Wen, Yang Gui-Fang, Gong Ling-Ling, Yuan Hong-Yin, Cui Ye-Jian, Wang Yan, Du Yu-Min, Li Yan, Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: Results of an in vitro and in vivo study, 10.1016/j.lfs.2006.09.040
  42. Qin Caiqin, Gao Junan, Wang Liansheng, Zeng Lintao, Liu Yi, Safety evaluation of short-term exposure to chitooligomers from enzymic preparation, 10.1016/j.fct.2005.11.009
  43. NISHIMURA YOSHIKAZU, KIM HEE-SUN, IKOTA NOBUO, ARIMA HIROMI, BOM HEE-SEUNG, KIM YOUNG-HO, WATANABE YOSHITO, YUKAWA MASAE, OZAWA TOSHIHIKO, Radioprotective Effect of Chitosan in Sub-lethally X-ray Irradiated Mice., 10.1269/jrr.44.53
  44. Lee Kyoung-Youl, Shibutani Makoto, Takagi Hironori, Arimura Takuro, Takigami Shu, Uneyama Chikako, Kato Natsumi, Hirose Masao, Subchronic toxicity study of dietary N-acetylglucosamine in F344 rats, 10.1016/j.fct.2003.12.005
  45. Anderson J.W., Nicolosi R.J., Borzelleca J.F., Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy, 10.1016/j.fct.2004.11.006
  46. Yang Y. M., Hu W., Wang X. D., Gu X. S., The controlling biodegradation of chitosan fibers by N-acetylation in vitro and in vivo, 10.1007/s10856-007-3013-x
  47. Zhang Hua, Neau Steven H., In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents, 10.1016/s0142-9612(02)00011-x
  48. Schipper Nicolaas G. M., Vårum Kjell M., Artursson Per, 10.1023/a:1016444808000
  49. Schipper Nicolaas G.M., Vårum Kjell M., Stenberg Patric, Ocklind Göran, Lennernäs Hans, Artursson Per, Chitosans as absorption enhancers of poorly absorbable drugs, 10.1016/s0928-0987(99)00032-9
  50. Agrawal Udita, Sharma Rajeev, Gupta Madhu, Vyas Suresh P., Is nanotechnology a boon for oral drug delivery?, 10.1016/j.drudis.2014.04.011
  51. Arai K, Bull Tokai Reg Fish Res Lab, 56, 89 (1968)
  52. Agnihotri Sunil A., Mallikarjuna Nadagouda N., Aminabhavi Tejraj M., Recent advances on chitosan-based micro- and nanoparticles in drug delivery, 10.1016/j.jconrel.2004.08.010
  53. Gades Matthew D., Stern Judith S., Chitosan Supplementation and Fecal Fat Excretion in Men, 10.1038/oby.2003.97
  54. Yin Lichen, Ding Jieying, He Chunbai, Cui Liming, Tang Cui, Yin Chunhua, Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery, 10.1016/j.biomaterials.2009.06.055
  55. Sonaje Kiran, Lin Yu-Hsin, Juang Jyuhn-Huarng, Wey Shiaw-Pyng, Chen Chiung-Tong, Sung Hsing-Wen, In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery, 10.1016/j.biomaterials.2008.12.066
  56. Du Xuli, Zhang Jian, Zhang Yan, Li Shuang, Lin Xia, Tang Xing, Zhang Yu, Wang Yanjiao, Decanoic acid grafted oligochitosan nanoparticles as a carrier for insulin transport in the gastrointestinal tract, 10.1016/j.carbpol.2014.04.048
  57. Woitiski Camile B., Sarmento Bruno, Carvalho Rui A., Neufeld Ronald J., Veiga Francisco, Facilitated nanoscale delivery of insulin across intestinal membrane models, 10.1016/j.ijpharm.2011.04.003
  58. Woitiski Camile B., Neufeld Ronald J., Soares Ana F., Figueiredo Isabel V., Veiga Francisco J., Carvalho Rui A., Evaluation of hepatic glucose metabolism via gluconeogenesis and glycogenolysis after oral administration of insulin nanoparticles, 10.3109/03639045.2011.653789
  59. Zhang Xiaoyan, Sun Muzhen, Zheng Aiping, Cao Deying, Bi Yunqi, Sun Jianxu, Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration, 10.1016/j.ejps.2012.01.002
  60. Semete B., Booysen L.I.J., Kalombo L., Venter J.D., Katata L., Ramalapa B., Verschoor J.A., Swai H., In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles, 10.1016/j.taap.2010.09.002
  61. Bhardwaj V., Ankola D. D., Gupta S. C., Schneider M., Lehr C.-M., Kumar M. N. V. Ravi, PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat, 10.1007/s11095-009-9965-4
  62. Semete Boitumelo, Booysen Laetitia, Lemmer Yolandy, Kalombo Lonji, Katata Lebogang, Verschoor Jan, Swai Hulda S., In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems, 10.1016/j.nano.2010.02.002
  63. SVENSON S, TOMALIA D, Dendrimers in biomedical applications—reflections on the field, 10.1016/j.addr.2005.09.018
  64. Thiagarajan Giridhar, Greish Khaled, Ghandehari Hamidreza, Charge affects the oral toxicity of poly(amidoamine) dendrimers, 10.1016/j.ejpb.2013.01.019
  65. Wiwattanapatapee Ruedeekorn, Carreño-Gómez Begoña, Malik Navid, Duncan Ruth, 10.1023/a:1007587523543
  66. Kalepu Sandeep, Manthina Mohanvarma, Padavala Veerabhadhraswamy, Oral lipid-based drug delivery systems – an overview, 10.1016/j.apsb.2013.10.001
  67. Silva A.C., González-Mira E., García M.L., Egea M.A., Fonseca J., Silva R., Santos D., Souto E.B., Ferreira D., Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): High pressure homogenization versus ultrasound, 10.1016/j.colsurfb.2011.03.035
  68. Rawat Manoj K., Jain Achint, Singh Sanjay, In Vivo and Cytotoxicity Evaluation of Repaglinide-Loaded Binary Solid Lipid Nanoparticles After Oral Administration to Rats, 10.1002/jps.22454
  69. Cho HJ, Int J Nanomedicine, 9, 495 (2014)
  70. Xue Mei, Jiang Zhen-zhou, Wu Tao, Li Ji, Zhang Liang, Zhao Yan, Li Xue-jun, Zhang Lu-Yong, Yang Shu-yu, Anti-inflammatory effects and hepatotoxicity of Tripterygium-loaded solid lipid nanoparticles on adjuvant-induced arthritis in rats, 10.1016/j.phymed.2012.06.006
  71. Zhou L, Pharmazie, 67, 304 (2012)
  72. Rogers James A., Anderson Keith E., The Potential of Liposomes in Oral Drug Delivery, 10.1615/critrevtherdrugcarriersyst.v15.i5.10
  73. Lv LZ, Int J Nanomedicine, 7, 4099 (2012)
  74. Buyukozturk Fulden, Benneyan James C., Carrier Rebecca L., Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics, 10.1016/j.jconrel.2009.10.005
  75. Iijima Sumio, Helical microtubules of graphitic carbon, 10.1038/354056a0
  76. Beg Sarwar, Rizwan Mohammad, Sheikh Asif M., Hasnain M. Saquib, Anwer Khalid, Kohli Kanchan, Advancement in carbon nanotubes: basics, biomedical applications and toxicity : Biomedical applications of carbon nanotubes, 10.1111/j.2042-7158.2010.01167.x
  77. Heister Elena, Neves Vera, Tîlmaciu Carmen, Lipert Kamil, Beltrán Vanesa Sanz, Coley Helen M., Silva S. Ravi P., McFadden Johnjoe, Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy, 10.1016/j.carbon.2009.03.057
  78. Ajima Kumiko, Yudasaka Masako, Murakami Tatsuya, Maigné Alan, Shiba Kiyotaka, Iijima Sumio, Carbon Nanohorns as Anticancer Drug Carriers, 10.1021/mp0500566
  79. Miyawaki Jin, Yudasaka Masako, Azami Takeshi, Kubo Yoshimi, Iijima Sumio, Toxicity of Single-Walled Carbon Nanohorns, 10.1021/nn700185t
  80. PULSKAMP K, DIABATE S, KRUG H, Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants, 10.1016/j.toxlet.2006.11.001
  81. Park Sungjin, An Jinho, Jung Inhwa, Piner Richard D., An Sung Jin, Li Xuesong, Velamakanni Aruna, Ruoff Rodney S., Colloidal Suspensions of Highly Reduced Graphene Oxide in a Wide Variety of Organic Solvents, 10.1021/nl803798y
  82. Rahmanian Nazanin, Hamishehkar Hamed, Dolatabadi Jafar Ezzati Nazhad, Arsalani Nasser, Nano graphene oxide: A novel carrier for oral delivery of flavonoids, 10.1016/j.colsurfb.2014.09.036
  83. Yang Kai, Gong Hua, Shi Xiaoze, Wan Jianmei, Zhang Youjiu, Liu Zhuang, In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration, 10.1016/j.biomaterials.2013.01.001
  84. Santos Helder, Peltonen Leena, Limnell Tarja, Hirvonen Jouni, Mesoporous Materials and Nanocrystals for Enhancing the Dissolution Behavior of Poorly Water-soluble Drugs, 10.2174/1389201014666131226150404
  85. Santos Hélder A, Mäkilä Ermei, Airaksinen Anu J, Bimbo Luis M, Hirvonen Jouni, Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications, 10.2217/nnm.13.223
  86. Ambrogio Michael W., Thomas Courtney R., Zhao Yan-Li, Zink Jeffrey I., Stoddart J. Fraser, Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine, 10.1021/ar200018x
  87. Salonen Jarno, Kaukonen Ann M., Hirvonen Jouni, Lehto Vesa-Pekka, Mesoporous Silicon in Drug Delivery Applications, 10.1002/jps.20999
  88. Jaganathan Hamsa, Godin Biana, Biocompatibility assessment of Si-based nano- and micro-particles, 10.1016/j.addr.2012.05.008
  89. Qu W, Int J Nanomedicine, 7, 4983 (2012)
  90. Moulari Brice, Pertuit David, Pellequer Yann, Lamprecht Alf, The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis, 10.1016/j.biomaterials.2008.08.009
  91. van der Zande Meike, Vandebriel Rob J, Groot Maria J, Kramer Evelien, Herrera Rivera Zahira E, Rasmussen Kirsten, Ossenkoppele Jan S, Tromp Peter, Gremmer Eric R, Peters Ruud JB, Hendriksen Peter J, Marvin Hans JP, Hoogenboom Ron LAP, Peijnenburg Ad ACM, Bouwmeester Hans, Sub-chronic toxicity study in rats orally exposed to nanostructured silica, 10.1186/1743-8977-11-8
  92. Hassankhani R, Environ Sci Pollut Res Int (2014)
  93. Vallet-Regi M., Rámila A., del Real R. P., Pérez-Pariente J., A New Property of MCM-41:  Drug Delivery System, 10.1021/cm0011559
  94. Fu Changhui, Liu Tianlong, Li Linlin, Liu Huiyu, Chen Dong, Tang Fangqiong, The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes, 10.1016/j.biomaterials.2012.12.043
  95. Salonen J., Laitinen L., Kaukonen A.M., Tuura J., Björkqvist M., Heikkilä T., Vähä-Heikkilä K., Hirvonen J., Lehto V.-P., Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs, 10.1016/j.jconrel.2005.08.017
  96. Shrestha Neha, Shahbazi Mohammad-Ali, Araújo Francisca, Zhang Hongbo, Mäkilä Ermei M., Kauppila Jussi, Sarmento Bruno, Salonen Jarno J., Hirvonen Jouni T., Santos Hélder A., Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers, 10.1016/j.biomaterials.2014.04.104
  97. Liu Dongfei, Bimbo Luis M., Mäkilä Ermei, Villanova Francesca, Kaasalainen Martti, Herranz-Blanco Barbara, Caramella Carla M., Lehto Vesa-Pekka, Salonen Jarno, Herzig Karl-Heinz, Hirvonen Jouni, Santos Hélder A., Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles, 10.1016/j.jconrel.2013.05.036
  98. Zhang Hongbo, Liu Dongfei, Shahbazi Mohammad-Ali, Mäkilä Ermei, Herranz-Blanco Bárbara, Salonen Jarno, Hirvonen Jouni, Santos Hélder A., Fabrication of a Multifunctional Nano-in-micro Drug Delivery Platform by Microfluidic Templated Encapsulation of Porous Silicon in Polymer Matrix, 10.1002/adma.201400953
  99. Bimbo Luis M., Sarparanta Mirkka, Santos Hélder A., Airaksinen Anu J., Mäkilä Ermei, Laaksonen Timo, Peltonen Leena, Lehto Vesa-Pekka, Hirvonen Jouni, Salonen Jarno, Biocompatibility of Thermally Hydrocarbonized Porous Silicon Nanoparticles and their Biodistribution in Rats, 10.1021/nn901657w
  100. Li Yu-Feng, Chen Chunying, Fate and Toxicity of Metallic and Metal-Containing Nanoparticles for Biomedical Applications, 10.1002/smll.201101059
  101. Hillyer Julián F., Albrecht Ralph M., Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles, 10.1002/jps.1143
  102. Pokharkar Varsha, Dhar Sheetal, Bhumkar Devika, Mali Vishal, Bodhankar Subhash, Prasad B. L. V., Acute and Subacute Toxicity Studies of Chitosan Reduced Gold Nanoparticles: A Novel Carrier for Therapeutic Agents, 10.1166/jbn.2009.1027
  103. Zhang, Toxicologic effects of gold nanoparticles in vivo by different administration routes, 10.2147/ijn.s8428
  104. Mura Simona, Nicolas Julien, Couvreur Patrick, Stimuli-responsive nanocarriers for drug delivery, 10.1038/nmat3776
  105. Kumari Monika, Rajak Sheik, Singh Shailendra P., Murty Upadhyayula S. N., Mahboob Mohammed, Grover Paramjit, Rahman Mohammed F., Biochemical alterations induced by acute oral doses of iron oxide nanoparticles in Wistar rats, 10.3109/01480545.2012.720988
  106. Singh Shailendra Pratap, Rahman M.F., Murty U.S.N., Mahboob M., Grover Paramjit, Comparative study of genotoxicity and tissue distribution of nano and micron sized iron oxide in rats after acute oral treatment, 10.1016/j.taap.2012.10.016
  107. 10.1002/smll.v5:15
  108. Shapira Alina, Assaraf Yehuda G., Epstein Dikla, Livney Yoav D., Beta-casein Nanoparticles as an Oral Delivery System for Chemotherapeutic Drugs: Impact of Drug Structure and Properties on Co-assembly, 10.1007/s11095-010-0222-7
  109. Chen Lingyun, Subirade Muriel, Chitosan/β-lactoglobulin core–shell nanoparticles as nutraceutical carriers, 10.1016/j.biomaterials.2005.03.011
  110. Golla Kishore, Bhaskar Cherukuvada, Ahmed Farhan, Kondapi Anand K., A Target-Specific Oral Formulation of Doxorubicin-Protein Nanoparticles: Efficacy and Safety in Hepatocellular Cancer, 10.7150/jca.7093
  111. Jos Angeles, Pichardo Silvia, Puerto María, Sánchez Elena, Grilo Antonio, Cameán Ana M., Cytotoxicity of carboxylic acid functionalized single wall carbon nanotubes on the human intestinal cell line Caco-2, 10.1016/j.tiv.2009.07.001
  112. Cicchetti Rosadele, Divizia Maurizio, Valentini Federica, Argentin Gabriella, Effects of single-wall carbon nanotubes in human cells of the oral cavity: Geno-cytotoxic risk, 10.1016/j.tiv.2011.09.017
  113. Folkmann Janne K., Risom Lotte, Jacobsen Nicklas R., Wallin Håkan, Loft Steffen, Møller Peter, Oxidatively Damaged DNA in Rats Exposed by Oral Gavage to C60 Fullerenes and Single-Walled Carbon Nanotubes, 10.1289/ehp.11922
  114. Kolosnjaj-Tabi Jelena, Hartman Keith B., Boudjemaa Sabah, Ananta Jeyarama S., Morgant Georges, Szwarc Henri, Wilson Lon J., Moussa Fathi, In VivoBehavior of Large Doses of Ultrashort and Full-Length Single-Walled Carbon Nanotubes after Oral and Intraperitoneal Administration to Swiss Mice, 10.1021/nn901573w
  115. Naya M., Kobayashi N., Mizuno K., Matsumoto K., Ema M., Honda K., Nakanishi J., Evaluation of the genotoxic potential of single-wall carbon nanotubes by using a battery of in vitro and in vivo genotoxicity assays, 10.1016/j.toxlet.2011.05.969